Showing results (1811-1820 of 1,985) with videos related to
Sort By:
Pageof 199
The Lancet. Neurology|November 19, 2011
Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategiesMaarten J Titulaer, Bethan Lang, Jan Jgm VerschuurenThe Lancet. Neurology|November 19, 2011
Modelling of Parkinson's disease in miceMarie-Françoise Chesselet, Franziska RichterThe Lancet. Neurology|June 10, 2011
Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registryTorbjörn Tomson, Dina Battino, Erminio Bonizzoni, et al.The Lancet. Neurology|December 21, 2007
Strategies to advance translational research into brain barriersEdward Neuwelt, N Joan Abbott, Lauren Abrey, et al.The Lancet. Neurology|April 15, 2014
Efficacy of occupational therapy for patients with Parkinson's disease: a randomised controlled trialIngrid H W M Sturkenboom, Maud J L Graff, Jan C M Hendriks, et al.The Lancet. Neurology|April 2, 2014
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trialPeter A Calabresi, Ernst-Wilhelm Radue, Douglas Goodin, et al.The Lancet. Neurology|April 2, 2014
Neuropsychiatric outcomes of strokeMaree L Hackett, Sebastian Köhler, John T O'Brien, et al.The Lancet. Neurology|April 8, 2014
Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trialAngel Chamorro, Sergio Amaro, Mar Castellanos, et al.The Lancet. Neurology|April 8, 2014
A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem studyLidia Sabater, Carles Gaig, Ellen Gelpi, et al.The Lancet. Neurology|March 29, 2014
End-of-life decisions in patients with severe acute brain injuryMarjolein Geurts, Malcolm R Macleod, Ghislaine J M W van Thiel, et al.Pageof 199